Health X Platform financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹447cr+49.7% on Q1 FY26
Net profit
₹2.0cr−92.5% on Q1 FY26
EBITDA margin
−1.9%−3.9 pts on Q1 FY26
EPS
₹0.80−89.4% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue447298+49.7%
EBITDA−8.46.1—
EBITDA margin−1.9%2.0%−3.9 pts
Profit before tax2.030.2−93.5%
Net profit2.026.6−92.5%
EPS₹0.80₹7.52−89.4%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹447 crNet profit₹2.0 crNet margin0.4%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
888————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
30.230.212.433.631.7
124124195——
22.122.10.00.00.0
1,004————
1,4681,3191,1111,3761,040
—+18.8%−19.2%+32.3%—
−66.5−52.1−56.05.4−44.0
−4.5%−4.0%−5.0%0.4%−4.2%
−73.9−58.7−61.9−3.7−52.2
−26.1−1.4−1345.9−99.5
−1.8%−0.1%−12.0%0.4%−9.6%
−₹6.35₹0.37−₹28.66₹2.79−₹22.70
—+101.3%−1,126.3%+112.3%—
—−73.8−17.338.2−104
—−14.9−10.4−14.2−27.9
−88.8−88.8−27.723.9−132
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEALTHX₹279.20

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹888 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————888.1
- Cash, Equiv & ST Investments31.733.612.430.230.2
+ Minority Interest——194.7124.4124.4
+ Total Debt0.00.00.022.122.1
Enterprise Value————1,004.4
Revenue1,039.81,375.71,111.01,319.31,467.7
Growth %, YoY—+32.3-19.2+18.8—
EBITDA-44.05.4-56.0-52.1-66.5
Margin %-4.230.39-5.04-3.95-4.53
EBIT-52.2-3.7-61.9-58.7-73.9
Net Income-99.55.9-133.5-1.4-26.1
Margin %-9.570.43-12.02-0.11-1.78
EPS, Adj (current shares)-22.702.79-28.660.37-6.35
Growth %, YoY—+112.3-1,126.3+101.3—
Cash from Operations-104.538.2-17.3-73.8—
Capital Expenditures-27.9-14.2-10.4-14.9—
Free Cash Flow-132.423.9-27.7-88.8-88.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Health X Platform financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

Health X Platform (NSE: HEALTHX) had a market capitalisation of ₹888 crore at the previous close (₹279.20 a share) and a price-to-book ratio of 1.39. In FY26 its consolidated net profit attributable to shareholders was ₹1.2 crore on revenue of ₹1,319 crore; in Q1 FY27 (April–June 2026) it was ₹2.5 crore, down 89.4% year on year. Its debt-to-equity ratio was 0.03 on 31 March 2026. Promoters held 74.07% of the shares on 30 September 2026.

Share price used
₹279.20 · previous close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Health X Platform at a glance · consolidated

Market cap
₹888 Crat ₹279.20 · previous close
PE ratio
n/aloss over the last 4 quarters
Price to book (PB)
1.39book value ₹201.47 a share
ROE (FY26)
0.2%
Debt to equity
0.03net cash ₹8.1 Cr
Promoter holding
74.07%unchanged vs 30 Jun 202630 September 2026
Net worth
₹641 Cr−4.3% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
−₹88.8 Cr
EPS (FY26)
₹0.37

Questions

What is the Health X Platform PE ratio today?

Health X Platform's PE ratio is not meaningful at the previous close: its consolidated net profit attributable to shareholders over the last four quarters (Q2 FY26 to Q1 FY27) was a loss of ₹20.2 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹888 crore at ₹279.20 a share.

What is the Health X Platform PB ratio (price to book value)?

Health X Platform's price-to-book (PB) ratio is 1.39 at the previous close: a market capitalisation of ₹888 crore divided by shareholders' equity (book value) of ₹641 crore on 31 March 2026. That is a book value of ₹201.47 per share against a share price of ₹279.20.

What is the Health X Platform debt to equity ratio?

Health X Platform's debt-to-equity ratio was 0.03 on 31 March 2026: borrowings, debt securities, deposits and subordinated debt of ₹22.1 crore against total equity of ₹765 crore. A year earlier, on 31 March 2025, it was 0.00.

What is the Health X Platform market cap?

Health X Platform's market capitalisation was ₹888 crore at the previous close: 3.18 crore shares at ₹279.20 each.

Is Health X Platform debt free?

No. Health X Platform had borrowings of ₹22.1 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹30.2 crore, so it held net cash of ₹8.1 crore.

What is the Health X Platform EPS?

Health X Platform's basic earnings per share (EPS) were ₹0.37 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to −₹6.35.

What is the Health X Platform net worth?

Health X Platform's net worth — shareholders' equity in its consolidated balance sheet — was ₹641 crore on 31 March 2026, down 4.3% from ₹670 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹888 crore at the previous close.

What is the Health X Platform promoter holding?

Promoters held 74.07% of Health X Platform on 30 September 2026, unchanged from the previous quarter and down 0.17 percentage points from 74.24% a year earlier, according to the shareholding pattern filed with NSE.

What is the Health X Platform free cash flow?

In FY26, Health X Platform generated ₹73.8 crore of cash from operations and spent ₹14.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹88.8 crore. In FY25 it was −₹27.7 crore.

What is the Health X Platform ROE and ROCE?

In FY26, Health X Platform's return on equity (ROE) was 0.2%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year).

What is the Health X Platform revenue and profit in FY26?

In FY26 (April 2025–March 2026), Health X Platform's consolidated net profit attributable to shareholders was ₹1.2 crore, against a loss of ₹91.2 crore in FY25, on revenue from operations of ₹1,319 crore (up 18.8%).

When are the Health X Platform next results?

Health X Platform has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

What is the Health X Platform book value per share?

Health X Platform's book value per share was ₹201.47 on 31 March 2026: shareholders' equity of ₹641 crore divided by the 3.18 crore shares in issue, down 4.3% from ₹210.58 a year earlier. The share price at the previous close was ₹279.20.

What are the Health X Platform latest quarterly results?

Health X Platform's latest results are for Q1 FY27 (April–June 2026), filed on 7 August 2026: consolidated net profit attributable to shareholders ₹2.5 crore, down 89.4% from ₹23.9 crore in Q1 FY26; revenue from operations ₹447 crore, up 49.7% year on year.

Health X Platform vs Suraksha Diagnostic: how do they compare?

In FY26, Health X Platform earned net profit attributable to shareholders of ₹1.2 crore on revenue of ₹1,319 crore, against ₹32.2 crore on ₹310 crore for Suraksha Diagnostic. Health X Platform's operating margin was −4.5% (Suraksha Diagnostic 17.4%) and its return on equity 0.2% (Suraksha Diagnostic 14.1%).

What is the Health X Platform shareholding pattern?

On 30 September 2026, Health X Platform's shares were held by promoters 74.07%, foreign portfolio investors (FII/FPI) 2.32%, domestic institutions (DII) 2.61% and retail and other non-institutional investors 21.00%. Over the year, FII holding was up 0.28 percentage points from 2.04% and DII holding was up 0.54 percentage points from 2.07%.

How does Health X Platform compare with its peers?

On FY26 consolidated figures, against Suraksha Diagnostic, Krsnaa Diagnostics and Nephrocare Health Services: Health X Platform's operating margin of −4.5% is the lowest of the four (Suraksha Diagnostic 17.4%, Krsnaa Diagnostics 15.7%, Nephrocare Health Services 13.7%; peer average 15.6%); its return on equity of 0.2% is the lowest of the four (Suraksha Diagnostic 14.1%, Krsnaa Diagnostics 10.9%, Nephrocare Health Services 6.9%; peer average 10.6%).

Where do these Health X Platform figures come from?

From Health X Platform's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.